CLOSURE Medical Corporation

Feb 19, 02
16:07 ET	CLOSURE Medical Reports Fourth Quarter and Year-End 2001 Results
Feb 12, 02
16:53 ET	CLOSURE Medical to Webcast Conference Call Discussing Fourth Quarter And Year-End 2001 Results
Jan 31, 02
12:27 ET	CLOSURE Medical Corporation to Participate in Merrill Lynch's Thirteenth Annual Global Pharmaceutical, Device and Biotechnology Conference
Jan 28, 02
08:45 ET	CLOSURE Medical Announces Planned Retirement of Robert V. Toni, President And Chief Executive Officer
Jan 24, 02
09:02 ET	CLOSURE Medical Corporation to Participate in the U.S. Bancorp Piper Jaffray Health Care Conference
Jan 16, 02
09:03 ET	DERMABOND Adhesive Receives FDA Approval for Enhanced Device Labeling
Nov 26, 01
11:48 ET	CLOSURE Medical Corporation to Participate in The Robertson Stephens Medical Conference
Nov 07, 01
09:41 ET	CLOSURE Medical Provides Johnson & Johnson Wound Management Exclusive Rights To Occlusive Dressing Technology, the Company's Fifth Major Product Platform
Oct 23, 01
16:04 ET	CLOSURE Medical Corporation Reports Record Revenue and Earnings for the Third Quarter and First Nine Months of 2001; Expects 30-35% Revenue Growth for 2002
Oct 16, 01
15:46 ET	James E. Niedel, Former Chief Science and Technology Officer Of GlaxoSmithKline plc, Joins Board of CLOSURE Medical Corporation
12:15 ET	CLOSURE Medical to Webcast Conference Call Discussing Third Quarter 2001 Results and Outlook for 2002
Jul 30, 01
16:35 ET	CLOSURE Medical Adopts Stockholder Rights Plan
Jul 24, 01
15:55 ET	CLOSURE Medical Corporation Reports Record Revenues for the Second Quarter And First Half of 2001
Jul 17, 01
10:41 ET	CLOSURE Medical to Webcast Second Quarter 2001 Earnings Results Conference Call
08:36 ET	CLOSURE Medical Announces Agreement with Abbott Laboratories for NEXABAND(R) Product Line for Veterinary Wound Care
May 29, 01
09:07 ET	CLOSURE Medical Signs Definitive Agreement With Johnson & Johnson Consumer Companies, Inc. for its Liquiderm(TM) Liquid Adhesive Bandage
Apr 24, 01
16:03 ET	CLOSURE Medical Corporation Reports First Quarter Profit
Apr 17, 01
11:51 ET	CLOSURE Medical to Webcast First Quarter 2001 Conference Call
Feb 20, 01
16:08 ET	CLOSURE Medical Corporation Reports Fourth Quarter and Year-End 2000 Results
Feb 16, 01
08:33 ET	CLOSURE Medical to Webcast Fourth-Quarter and Year-End 2000 Conference Call
Feb 06, 01
08:34 ET	CLOSURE Medical Enters Into Cooperative Research Agreement to Develop Medical Adhesive for the Treatment of Emphysema
Jan 11, 01
19:00 ET	CLOSURE Medical Corporation Provides Guidance for Fourth Quarter 2000 and For Fiscal Year 2001 Including the Effects of Adopting Staff Accounting Bulletin No. 1 ("SAB 101")
Jan 09, 01
15:59 ET	CLOSURE Medical Corporation to Discuss Colgate Oral Pharmaceuticals, Inc. Agreement, Financial Performance Outlook for 2001 and Effects of Adoption of SAB 101
Jan 05, 01
16:17 ET	CLOSURE'S CEO Announces Plan to Sell Shares Under New SEC Rule 10b5-1 During 2001
Dec 21, 00
13:59 ET	CLOSURE Medical Corporation Announces Agreement Granting Colgate Oral Pharmaceuticals, Inc. Exclusive Rights to SOOTHE-N-SEAL(TM)
Dec 08, 00
16:28 ET	CLOSURE Medical Corporation Reiterates Status of Partnership Arrangements
Oct 26, 00
17:54 ET	CLOSURE Medical Corporation Reports Third Quarter Results
Oct 23, 00
12:43 ET	CLOSURE Medical Schedules Date for Third-Quarter Financial Results and Conference Call
Aug 01, 00
08:32 ET	CLOSURE Medical Corporation Files a 510(k) Application for U.S. Marketing Clearance of Its Liquiderm(TM) Liquid Adhesive Bandage
Jul 25, 00
16:41 ET	Closure Medical Corporation Reports Second Quarter Results
May 05, 00
08:04 ET	Closure Medical Names Benny Ward as Chief Financial Officer
Apr 25, 00
16:00 ET	CLOSURE Medical Corporation Reports First Quarter Results
Mar 31, 00
16:32 ET	CLOSURE Medical Announces Resignation of Chief Financial Officer
Mar 28, 00
10:40 ET	CLOSURE Medical Announces Human Clinical Study for LIQUIDERM(TM) Liquid Healing Bandage
Feb 16, 00
12:36 ET	CLOSURE Medical Corporation Receives Clearance for Marketing DERMABOND(R) In Japan
09:33 ET	CLOSURE Medical Corporation Reports Fourth Quarter Results
Dec 08, 99
08:15 ET	CLOSURE Medical Corporation Elects Ronald A. Ahrens as Chairman of its Board Of Directors
Oct 21, 99
08:05 ET	CLOSURE Medical Corporation Reports Third Quarter Results
Sep 07, 99
11:16 ET	Closure Medical Corporation Announces FDA Approval of Soothe-N-Seal(TM) Canker Sore Relief
Aug 04, 99
12:44 ET	CLOSURE Medical Corporation Awarded U.S. Patent Relevant To DERMABOND
Jul 15, 99
16:15 ET	CLOSURE Medical Corporation Reports Second Quarter 1999 Results
Jun 08, 99
08:10 ET	CLOSURE Medical Corporation Announces Filing of 510(K) For SOOTHE-N-SEAL(TM) Canker Sore Relief
Apr 22, 99
08:31 ET	CLOSURE Medical Corporation Reports First Quarter Results
Feb 10, 99
08:05 ET	CLOSURE Medical Corporation Reports Fourth Quarter Results
Jan 04, 99
11:41 ET	Ronald A. Ahrens Joins CLOSURE Medical Corporation Board Of Directors
Nov 23, 98
13:17 ET	One-Year Follow-Up Highlights Excellent Cosmetic Results With DERMABOND* Topical Skin Adhesive
Oct 21, 98
17:00 ET	CLOSURE Medical Corporation Announces Third Quarter Earnings
Aug 27, 98
08:53 ET	CLOSURE Medical Announces FDA Approval of DERMABOND
Jul 27, 98
15:06 ET	CLOSURE Medical Corporation Announces Second Quarter Results
Jun 03, 98
08:45 ET	CLOSURE Medical Completes Pilot Clinical Study for Treatment of Oral Ulcers
Apr 20, 98
22:27 ET	CLOSURE Medical Corporation Announces First Quarter Results
Mar 31, 98
22:25 ET	Debra L. Pawl Joins Closure Medical Corporation as Vice President and General Counsel
Mar 11, 98
08:58 ET	CLOSURE Medical Relocates to 50,000 Square Foot Facility
Feb 04, 98
10:10 ET	CLOSURE Medical Corporation Receives ISO-9001 Registration
Feb 02, 98
11:54 ET	CLOSURE Medical Corporation Reports Fourth Quarter Results
Jan 30, 98
14:38 ET	FDA Advisory Panel Recommends Approval of Closure Medical Corporation's DERMABOND Topical Skin Cohesive
Jan 22, 98
13:00 ET	Dennis D. Burns Joins CLOSURE Medical Corporation as General Manager of Strategic Business Unit
Dec 18, 97
12:03 ET	CLOSURE Medical Advised of DERMABOND(TM) Review By FDA Advisory Panel on January 30, 1998
Nov 18, 97
12:55 ET	Closure Medical Corporation Secures $3 Million Credit Facility
Oct 24, 97
09:00 ET	Closure Medical Corporation Reports Third Quarter Results
Oct 07, 97
15:10 ET	Closure Medical Corporation Responds To Warning Letter
Aug 21, 97
09:00 ET	CLOSURE Medical Corporation Receives European Marketing Approval
Aug 11, 97
09:01 ET	CLOSURE Medical Corporation Reports Second Quarter Results; Concludes Successful Follow-On Offering April 2, 1997
Jul 29, 97
09:01 ET	Richard W. Miller Joins Closure Medical Corporation Board of Directors
Jun 10, 97
09:03 ET	William M. Cotter Joins Closure Medical Corporation as Vice President - Manufacturing and Operations
May 08, 97
08:57 ET	CLOSURE Medical Corporation Reports First Quarter Results
Apr 02, 97
13:24 ET	CLOSURE Medical Corporation Completes Sale of 1.725 Million Shares